There is a good deal of information about cpt 11 (Camptosar, irinotecan) at
http://www.meds.com. However, there is no information there about its use
in treatment of brain tumors. I suggest that you try a search engine such
as Alta Vista and search for "cpt 11 AND brain tumor" in an advanced
search. Also use the generic name (irinotecan) for searches. You may also
want to search for clinical trials at the National Cancer Institute site.
At 07:06 PM 12/22/97 -0500, you wrote:
>I need to hear from anyone w/ information on cpt 11. After watching the
>news last night, 12/21/97 and seeing a story on a Mr. Waldbauer. This
>gentleman had brain tumors the size of small oranges that after approx.
>1 year of treatment had shrunk to about the size of his fingertip. My
>sister-in-law also is suffering from tumors, (begign), and I would
>appreciate any info. on possible sources of help.
>
>Thanks and God Bless.
>------------------------------------------------------------------------
>This is an automatically-generated notice. If you'd like to be removed
>from the mailing list, please visit the Medicine-On-Line Discussion Forum
>at <http://www.meds.com/con_faq.html>, or send an email message to:
>majordomo@lists.meds.com
>with the subject line blank and the body of the message containing the line:
>unsubscribe mol-cancer your-email-address
>where the phrase your-email-address is replaced with your actual email
>address.
>------------------------------------------------------------------------
>
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
